Nouvelle déclaration d'incident
No de la demande: 2012-5071
Numéro de référence du titulaire d'homologation: 120060037
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: TENNESSEE
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 2724-811-270
Nom du produit: Bio Spot Defense Flea And Tick Spot On For Dogs 32-55 lbs
Liquide
Oui
Unités: mL
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Dog / Chien
Australian Shepherd Mix
1
Homme
3.5
31.0
lbs
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>2 hrs <=8 hrs / > 2 h < = 8 h
Système
Persisted until death
Oui
Oui
7
Hour(s) / Heure(s)
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On May 7, 2012 the owner observed that the dog had diarrhea, was lethargic, had bradypnea, and was vomiting. On May 8, 2012 the owner took the dog to the veterinarian, where the veterinarian told her that the dog had a hemorrhage in the gut. Later that evening, the owner contacted the Animal Product Safety Service (APSS) to obtain help. The APSS veterinarian stated that per label application of the flea and tick product is considered safe and would not cause the signs the dog was experiencing and that the casual transfer of a different flea product from another pet to him, would also not cause the signs. The APSS veterinarian recommended that the owner have her regular veterinarian call for information.
Mort
The APSS veterinarian stated that both products were considered to have a doubtful likelihood of causing the clinical situation. A short time after the owner contacted the APSS, the owner's regular veterinarian called the APSS to update the case. The owner's regular veterinarian stated that the dog was bathed, given fluid therapy, had radiographs taken which revealed blood in the abdomen, had an ultrasound of the abdomen and thorax done, had a complete blood count, had a chemistry profile, had a differential blood smear that revealed normal platelets present with clumping, was given a vitamin K injection subcutaneously, and had a cytology test that revealed no specific abnormalities. The owner's regular veterinarian said that the serum alanine aminotransferase was recorded as 275.0 units per liter (U/L), which was high; the white blood cell count was low; the hematocrit value was in the normal range and the activated clotting time was prolonged with a time of 60.0 minutes recorded. Later that evening, the owner's regular veterinarian noted that the dog had labored breathing and gave the dog endotrachial intubation and ventilatory support. The APSS veterinarian recommended that the owner's regular veterinarian continue to provide symptomatic and supportive care to the dog and call back with questions. On May 10, 2012 an APSS assistant called the owner's regular veterinarian to update the case. The owner's regular veterinarian stated that symptomatic and supportive care was provided to the dog on the evening of May 8, 2012, and a blood transfusion was done later that night. The owner's regular veterinarian stated that shortly after the blood transfusion, the dog died. A few minutes after the owner's regular veterinarian called to update the case, an APSS technician called the owner's regular veterinarian to discuss a necropsy. The owner's regular veterinarian stated that they were having a necropsy done, and the APSS technician requested that the owner's regular veterinarian send a copy of the necropsy results.